Proneural–mesenchymal hybrid glioblastoma cells are resistant to therapy and dependent on nuclear import
Neuro-Oncology · 2025
DOI: 10.1093/neuonc/noaf160 ↗Kurz gefasst
Fachartikel in der Zeitschrift Neuro-Oncology, 2025. Verfasst von Guillaume Bourmeau und 19 weiteren Autor:innen. Beteiligte Einrichtung: Institut Curie, INSERM U1339-CNRS UMR3666, Tumor Microenvironment Lab, Université Paris-Saclay, Orsay, France. Hauptthemen laut MEDLINE: Glioblastoma, Brain Neoplasms, Active Transport, Cell Nucleus, Drug Resistance, Neoplasm. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 59 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: European Research Council, Institut National du Cancer, Paris-Saclay University.
Abstract (Originalsprache)
Background
Despite extensive research efforts, glioblastoma (GBM) remains a deadly disease with poor prognosis. Although previous studies have identified various cell states within GBM tumors, the molecular mechanism underlying adaptive GBM cell plasticity induced by conventional therapy remains unclear.
Methods
We used fluorescent reporters for proneural (PN) and mesenchymal (MES) subtypes to monitor GBM cell plasticity in real-time across multiple patient-derived cell lines. This approach revealed cells that concurrently expressed both PN and MES markers. To investigate this unique hybrid population, we implemented a comprehensive methodological approach encompassing bulk and single-cell RNA sequencing, single-cell ChIP sequencing, nuclear proteomics, high-resolution imaging, orthotopic mouse models, clinical dataset analysis, and pharmacological and genetic techniques. This multifaceted strategy allowed us to gain functional and molecular insights into this distinct cellular population.
Results
We showed that these hybrid cells are increased by conventional therapies, and are resistant to these therapies. At the molecular level, hybrid cells display significant alterations in chromatin structure and nuclear protein composition, elevated transcriptional activity, Myc activation, and improved transport between the nucleus and cytoplasm. Genetic and pharmaceutical inhibition of the nuclear import/export shuttling machinery, increased in hybrid cells, effectively suppressed adaptive GBM cell plasticity and hybrid identity, thereby enhancing the sensitivity of GBM cells to therapies.
Conclusions
Our results indicate that GBM hybrid cells play a crucial role in chemoradiation resistance. The nuclear transport machinery presents a potential therapeutic target for hybrid cells, offering a way to counteract the typical resistance to treatment observed in GBM.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Institut Curie, INSERM U1339-CNRS UMR3666, Tumor Microenvironment Lab, Université Paris-Saclay, Orsay, France.
- Nuffield Department of Medicine, Ludwig Institute for Cancer Research, University of Oxford, Oxford, UK.
- Department of Computational and Quantitative Medicine, Hematologic Malignancies Research Institute and Beckman Research Institute, Duarte, California, USA.
- Single Cell Initiative, Institut Curie, PSL University, Paris, France.
- Translational Research Department, Institut Curie, PSL University, Paris, France.
- CNRS UMR3244, Institut Curie, PSL University, Paris, France.
ORCID-Profile: Guillaume Bourmeau, Jeremy Raymond, Alberto Ballestín, Juliette Reveilles, Valentino Ribecco, Damarys Loew, Gaetano Gargiulo, Vidhya M Ravi, Kevin Joseph, Giorgio Seano
Förderung
- European Research Council
- Institut National du Cancer
- Paris-Saclay University
- European Union's Horizon 2020
- Agence Nationale de la Recherche
- ITMO-Cancer Aviesan
- SiRIC-Curie
- Fondation pour la Recherche Médicale
Zitieren
APA
Bourmeau, G., Anezo, O., Raymond, J., Ballestín, A., Pichol-Thievend, C., Reveilles, J., Thomas, A., Wang, L., Miranda, M., Moutaux, E., Liva, S., Ribecco, V., Besse, L., Dingli, F., Loew, D., Vallot, C., Gargiulo, G., Ravi, V. M., Joseph, K., & Seano, G. (2025). Proneural–mesenchymal hybrid glioblastoma cells are resistant to therapy and dependent on nuclear import. Neuro-Oncology. https://doi.org/10.1093/neuonc/noaf160
Vancouver
Bourmeau G, Anezo O, Raymond J, Ballestín A, Pichol-Thievend C, Reveilles J, et al. Proneural–mesenchymal hybrid glioblastoma cells are resistant to therapy and dependent on nuclear import. Neuro-Oncology. 2025. doi:10.1093/neuonc/noaf160
BibTeX
@article{Bourmeau2025,
author = {Bourmeau, Guillaume and Anezo, Oceane and Raymond, Jeremy and Ballestín, Alberto and Pichol-Thievend, Cathy and Reveilles, Juliette and Thomas, Adrien and Wang, Lin and Miranda, Melanie and Moutaux, Eve and Liva, Stephane and Ribecco, Valentino and Besse, Laetitia and Dingli, Florent and Loew, Damarys and Vallot, Celine and Gargiulo, Gaetano and Ravi, Vidhya M and Joseph, Kevin and Seano, Giorgio},
title = {Proneural–mesenchymal hybrid glioblastoma cells are resistant to therapy and dependent on nuclear import},
journal = {Neuro-Oncology},
year = {2025},
doi = {10.1093/neuonc/noaf160}
}
EUVIMED